Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZN) Research & Development (2021 - 2025)

Surrozen has reported Research & Development over the past 5 years, most recently at $9.0 million for Q4 2025.

  • Quarterly results put Research & Development at $9.0 million for Q4 2025, up 68.06% from a year ago — trailing twelve months through Dec 2025 was $29.4 million (up 38.96% YoY), and the annual figure for FY2025 was $29.4 million, up 38.96%.
  • Research & Development for Q4 2025 was $9.0 million at Surrozen, up from $7.8 million in the prior quarter.
  • Over the last five years, Research & Development for SRZN hit a ceiling of $50.0 million in Q3 2021 and a floor of $5.2 million in Q3 2024.
  • Median Research & Development over the past 5 years was $7.9 million (2023), compared with a mean of $9.7 million.
  • Biggest five-year swings in Research & Development: plummeted 82.75% in 2022 and later skyrocketed 68.06% in 2025.
  • Surrozen's Research & Development stood at $10.9 million in 2021, then fell by 13.37% to $9.4 million in 2022, then tumbled by 35.41% to $6.1 million in 2023, then fell by 12.22% to $5.4 million in 2024, then skyrocketed by 68.06% to $9.0 million in 2025.
  • The last three reported values for Research & Development were $9.0 million (Q4 2025), $7.8 million (Q3 2025), and $6.0 million (Q2 2025) per Business Quant data.